Cerba Healthcare News and Activities

Cerba Healthcare is owned by EQT.

EQT is one of the...

• Forbes Global 2000 (#1281);
• Russell 3000;
• Stoxx 600;
• TOB Iconic 10,000.

EQT is a company listed under the stock ticker EQT (SE).

EQT has a direct presence in 18 countries.

EQT has 59 subsidiaries including Anticimex, Atos Medical and Avetta.

They are in:

• Food15%
• Business Services13%
• Other72%

Acquisition, funding and merger involving EQT.

• EQT has acquired Seven Seas Water (posted on May 23 2025).
• EQT has acquired Perficient (posted on October 3 2024).
• WSO2 and EQT have announced they will merge  (posted on August 19 2024)..
• EQT has announced the acquisition of Perficient  (posted on May 8 2024).
• EQT has announced the acquisition of WSO2  (posted on May 7 2024).
• EQT has acquired Radius Global Infrastructure (posted on September 22 2023).
• See more news about EQT Hide news involving EQT

View the org chart displaying its 26 main executives

Most searched biographies at Cerba Healthcare

• Emmanuel Ligner, Chief Executive Officer
• Aurélie Driss-Corbin, Chief Executive Officer
• Eric Ellul, Supervisory Board Member

Popular executive movements at EQT

• Ricardo Reyes, who is Global Head of Communications and External Affairs will soon leave the company  (posted on June 4 2025).
• Bahare Haghshenas, who is Global Head of Sustainable Transformation will soon leave the company  (posted on June 4 2025).
• Suzanne Donohoe, who is Chief Commercial Officer and Global Head of EQT-Ext will soon leave the company  (posted on June 4 2025).

Click here to view some more movements at EQT

Create your alert
to follow the executive moves at Cerba Healthcare.

EQT has 2,347 competitors including Incyte (United States (USA)), Anthos Therapeutics (United States (USA)) and Valneva (France).

Popular M&A news in Biotechnology

• The new name of Synaptogenix is TAO Synergies. (posted on July 3 2025).
• AbbVie has announced the acquisition of Capstan Therapeutics  (posted on July 1 2025).
• Neuron23 has just announced a $97 Million fundraising (posted on June 30 2025).

Popular contacts in Biotechnology

• Jasbir Seehra - Chief Executive Officer and Chairman of the Board at Keros Therapeutics
• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Andrea Jackson - Director at Ultivue

Learn more about the Biotechnology industry

Press releases by Cerba Healthcare

Social media about Cerba Healthcare

• Cerba Healthcare on Wikipedia, Google News & Yahoo Finance
• Cerba Healthcare on LinkedIn, Twitter & YouTube